Published: Guidance, quality standards and advice
Showing 941 to 950 of 2494
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Avelumab with axitinib for untreated advanced renal cell carcinoma | TA645 | ||
| Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal) | TA646 | ||
| Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal) | TA647 | ||
| Helge for detecting haemolysis | MIB225 | ||
| Community pharmacies: promoting health and wellbeing | QS196 | ||
| Faltering growth | QS197 | ||
| High-sensitivity troponin tests for the early rule out of NSTEMI | DG40 | ||
| FebriDx for C-reactive protein and myxovirus resistance protein A testing | MIB224 | ||
| Anaphylaxis: assessment and referral after emergency treatment | CG134 | ||
| Perioperative care in adults | NG180 |